Methods of treating diabetes by blocking vegf-mediated activity

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 48/00 (2006.01) A61K 31/19 (2006.01) A61K 31/70 (2006.01) A61K 31/7088 (2006.01) A61K 38/18 (2006.01) A61K 39/385 (2006.01) A61K 39/395 (2006.01) A61P 3/10 (2006.01) C07K 14/52 (2006.01) C07K 14/71 (2006.01) C07K 16/28 (2006.01) C07K 19/00 (2006.01)

Patent

CA 2519787

Methods of treating diabetes in mammals, particularly humans, by blocking or inhibiting VEGF-mediated activity. A preferred inhibitor of VEGF-mediated activity is a VEGF antagonist such as a VEGF trap capable of binding and blocking VEGF.

L'invention concerne des méthodes permettant de traiter le diabète chez des mammifères, notamment chez l'homme, par blocage ou inhibition de l'activité induite par le facteur de croissance endothéliale. Un inhibiteur préféré de l'activité induite par le facteur de croissance endothéliale est un antagoniste du facteur de croissance endothéliale, tel qu'un piège du facteur de croissance endothéliale apte à fixer et à bloquer le facteur de croissance endothéliale.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Methods of treating diabetes by blocking vegf-mediated activity does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods of treating diabetes by blocking vegf-mediated activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of treating diabetes by blocking vegf-mediated activity will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2048129

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.